We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+8.22%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+468.9%
AUM
$920B
AUM Growth
+$99.4B
Cap. Flow
+$40.5B
Cap. Flow %
4.41%
Top 10 Hldgs %
19.57%
Holding
7,602
New
674
Increased
3,069
Reduced
2,328
Closed
737

Sector Composition

Rank Sector Weight
1 Technology 19.48%
2 Healthcare 10.48%
3 Financials 8.96%
4 Consumer Discretionary 8.42%
5 Industrials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUIZ
6076
Huize Holding Ltd
HUIZ
$12M
$2.12K ﹤0.01%
+309
New +$1.89K
RLMD icon
6077
Relmada Therapeutics
RLMD
$540M
$2.11K ﹤0.01%
859
-20,122
-96% -$55.6K
PROV icon
6078
Provident Financial
PROV
$111M
$2.09K ﹤0.01%
162
+130
+406% +$1.66K
ETG
6079
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.74B
$2.07K ﹤0.01%
124
-13,000
-99% -$210K
GF
6080
New Germany Fund
GF
$182M
$2.06K ﹤0.01%
+229
New +$2.04K
UBX
6081
DELISTED
Unity Biotechnology
UBX
$2.05K ﹤0.01%
+803
New +$2.12K
RFEM icon
6082
First Trust RiverFront Dynamic Emerging Markets ETF
RFEM
$75.3M
$2.02K ﹤0.01%
37
+7
+23% +$377
PHI icon
6083
PLDT
PHI
$4.32B
$2.01K ﹤0.01%
86
+72
+514% +$1.62K
AAOI icon
6084
Applied Optoelectronics
AAOI
$6.14B
$2K ﹤0.01%
336
GGZ
6085
Gabelli Global Small and Mid-Cap Value Trust
GGZ
$122M
$1.98K ﹤0.01%
+165
New +$1.89K
VAL.WS icon
6086
Valaris Ltd Warrants
VAL.WS
$590M
0
SMWB icon
6087
Similarweb
SMWB
$627M
$1.97K ﹤0.01%
300
-386
-56% -$2.34K
NPCT icon
6088
Nuveen Core Plus Impact Fund
NPCT
$279M
$1.96K ﹤0.01%
+197
New +$1.99K
ECAT icon
6089
BlackRock ESG Capital Allocation Term Trust
ECAT
$1.48B
$1.96K ﹤0.01%
125
-97,523
-100% -$1.51M
AIVI icon
6090
WisdomTree International AI Enhanced Value Fund
AIVI
$60.6M
$1.96K ﹤0.01%
50
+1
+2% +$40
NUTX
6091
Nutex Health
NUTX
$967M
$1.95K ﹤0.01%
31
-1,293
-98% -$111K
NYMX
6092
DELISTED
Nymox Pharmaceutical Corp
NYMX
$1.94K ﹤0.01%
10,219
+2,475
+32% +$974
IRAAW
6093
DELISTED
Iris Acquisition Corp Warrant
IRAAW
0
PRLHW
6094
DELISTED
Pearl Holdings Acquisition Corp Warrant
PRLHW
0
YRD
6095
Yiren Digital
YRD
$93.6M
$1.93K ﹤0.01%
850
IRNT
6096
DELISTED
IronNet, Inc.
IRNT
$1.91K ﹤0.01%
9,140
-42,302
-82% -$10.5K
NRSN icon
6097
NeuroSense Therapeutics
NRSN
$17.3M
$1.9K ﹤0.01%
+1,304
New +$2.28K
KF
6098
Korea Fund
KF
$216M
$1.9K ﹤0.01%
+82
New +$1.83K
IMGN
6099
CALL
DELISTED
Immunogen Inc
IMGN
$1.89K ﹤0.01%
100
-186,600
-100% -$2.2M
SYRS
6100
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.88K ﹤0.01%
596

Similar funds

JP Morgan Chase's Q2 2023 Portfolio in Review

As of Q2 2023, JP Morgan Chase held 7,602 positions worth $920B, up 12% from $821B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

JP Morgan Chase deployed $40.5B of net new capital in Q2 2023, opening 674 new positions and adding to 3,069 existing holdings. Its largest new stake was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $3.22B trimmed.

  • JP Morgan Chase's largest Q2 2023 buy was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
  • JP Morgan Chase added most to Microsoft in Q2 2023, an estimated $5.77B increase.
  • JP Morgan Chase's biggest Q2 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $3.22B.
  • JP Morgan Chase fully exited DCP Midstream, LP in Q2 2023, selling an estimated $328M.
  • JP Morgan Chase's ten largest holdings make up 20% of its $920B portfolio in Q2 2023.
  • JP Morgan Chase opened 674 new positions and closed 737 in Q2 2023.
  • JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $920B.

Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.